Microfluidics: FAQ on the technology
29.07.2025
Diagnostics, analytics, research - microfluidics is a superpower for medicine and medical technology.
Five important microtechnologies
20.05.2025
Microtechnology has tiny dimensions but a huge impact: complex components and systems are created in the smallest spaces.
Fraunhofer IAF
New virtual application lab for quantum sensing
07.04.2025
Fraunhofer IAF has developed a virtual application lab to promote the use of quantum sensors in industry, allowing interactively measurements.
Precision in the smallest space
24.01.2025
In order to deliver precise results, microfluidic chips must also be produced with high precision.
Julia Siekmann, Kiel University
New production method for an antiviral coating
07.10.2024
Researchers have investigated and compared six biomedical coating materials to understand their interactions with cells, skin and viruses.
Envato/YouraPechkin
Sensors – hidden heroes?
10.06.2024
They monitor, transmit and control – sensors in medical technology. Hardly any device can do without them.
Advancing immune cell analysis with micro-robots
28.02.2024
UChicago engineers microscopic robots that bind immune cells, revolutionizing analysis and boosting future immunotherapy design.
ninelutsk / Envato
Small technology for powerful hearing
14.12.2023
The smallest components are needed for hearing aids. We take a look at the microtechnology in devices.
Leibniz-IPF, Ivan Minev
New era of cyborganics
29.11.2023
The ERC is funding research into water-based electronics that could create seamless interfaces between biological tissue and machines.
FemtoGLASS for glass and sapphire
13.11.2023
WOP/Workshop of Photonics shows FemtoGLASS, a new device for laser cutting technology, in the video.
Aaron Elbourne and colleagues, RMIT University
Ultrathin nanotech promises to help tackle antibiotic resistance
14.09.2023
Nano-thin material kills superbugs - future use in wound dressings and implants to fight infections.
Joakim Palmqvist
Biosensors to detect tumors, viruses and bacterial diseases
05.09.2023
Linnaeus University invests SEK 35M in biosensor tech to enable faster, affordable diagnoses and potential at-home tests for serious diseases.
KIMM
3D bioprinting technology to be used for removing cancer cells
13.07.2023
KIMM develops the world’s first 3D bioprinting technology that enhances the function of NK immune cells. The new technology is expected to improve effectiveness of cancer treatment.
Empa
Antibiotics crisis: rapid test for sepsis with nanoparticles
13.06.2023
For Qun Ren, every minute counts. The Empa researcher and her team are currently developing a diagnostic procedure that can detect life-threatening blood poisoning caused by staphylococcus bacteria rapidly.
WFIRM
Bioprinting research makes history when it soars to the ISS
17.05.2023
The Wake Forest Institute for Regenerative Medicine (WFIRM) will make history this month when the first bioprinted solid tissue constructs soar to the International Space Station (ISS) on board the next all private astronaut mission by commercial space leader Axiom Space.
Max Planck Institute for Molecular Biomedicine
Microelectrode array: hammock for brain organoids
20.04.2023
Novel microelectrode array system enables long-term cultivation and electrophysiological analyses of brain organoids.
HZDR/Sandoval Bojorquez
Nanobiosensor developed for detecting SARS-CoV-2
31.03.2023
Infection and immunity status of the population are considered key parameters for handling pandemics. For this purpose, detecting antigens and antibodies is of great importance. The devices currently used for this purpose - what are known as point-of-care (POC) devices- are one option for rapid screening.
Messe Düsseldorf / ctillmann
Decentralization of diagnostics
22.03.2023
The coronavirus pandemic has given point-of-care diagnostics a boost. But where is the diagnostic journey heading?
Fraunhofer IPK / Larissa Klassen
New technologies for producing mRNA-based pharmaceuticals
21.03.2023
mRNA-based vaccines have been one of the key elements in the fight against the coronavirus. The technology was originally developed for cancer therapy and can be used to treat many diseases. Together with partners, Fraunhofer IPK is now researching how mRNA therapeutics and other medication can be better produced and more effectively applied.